Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

ClinicalTrials.gov ID: NCT00003634

Public ClinicalTrials.gov record NCT00003634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind Placebo Controlled Trial of Intravenous OvaRex MAb-B43.13 as Post Chemotherapy Consolidation for Ovarian Tubal and Peritoneal Carcinoma

Study identification

NCT ID
NCT00003634
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AltaRex
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

  • oregovomab Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 1998
Primary completion
Not listed
Completion
Not listed
Last update posted
Nov 5, 2013

Started 1998

United States locations

U.S. sites
29
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Alta Bates Comprehensive Cancer Center Berkeley California 94704
USC/Norris Comprehensive Cancer Center Los Angeles California 90033-0800
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1781
Chao Family Comprehensive Cancer Center Orange California 92868
Wilshire Oncology Medical Center Pomona California 91767
Stanford University School of Medicine Stanford California 94305-5317
University of Colorado Cancer Center Denver Colorado 80262
Patty Berg Cancer Center Fort Myers Florida 33901
University of Florida Health Science Center - Jacksonville Jacksonville Florida 32209
Walt Disney Memorial Cancer Institute Orlando Florida 32804
University of Chicago Cancer Research Center Chicago Illinois 60637
Saint Mary's Hospital East Saint Louis Illinois 62201
Lutheran General Cancer Care Center Park Ridge Illinois 60068
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
Alton Ochsner Medical Foundation Hospital New Orleans Louisiana 70121
Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland 21201
New England Medical Center Hospital Boston Massachusetts 02111
Henry Ford Hospital Detroit Michigan 48202
University of Minnesota Medical School Minneapolis Minnesota 55455
Ellis Fischel Cancer Center Columbia Missouri 65203
North Shore University Hospital Manhasset New York 11030
State University of New York - Upstate Medical University Syracuse New York 13210
University of Oklahoma Oklahoma City Oklahoma 73190
Spartanburg Regional Medical Center Spartanburg South Carolina 29303
Baptist Regional Cancer Center - Knoxville Knoxville Tennessee 37901
University of Texas Southwestern Medical School Dallas Texas 75235-9032
U.S. Oncology Houston Texas 77060
Cancer Center, University of Virginia HSC Charlottesville Virginia 22908
Swedish Hospital Tumor Institute Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2013 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003634 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →